For its first fiscal quarter (ending March 31), Church & Dwight Co Inc (NYSE: CHD) has reported a 13% increase in E.P.S. from $0.83 a year ago to $0.94 in the current quarter. This performance […]
Cardinal Health Inc (NYSE: CAH) has reported E.P.S. of $1.06 for its third fiscal quarter (ending March 31) versus $1.35 for the same period a year ago — a decline of -21%. Relative to the […]
Bright Horizons Family Solutions (NYSE: BFAM) has reported earnings for its first fiscal quarter (ending March 31) of $0.29 versus $0.14 for the same period a year ago — an increase of 107%. Relative to […]
On 5/2/24, Aviat Networks Inc (NASDAQ: AVNW) stock suffered a major decline of -16.4%, closing at $28.40. Moreover, trading volume in this decline was exceptionally high at 920% of normal. The stock has been strong […]
Astronics Corp (NASDAQ: ATRO) has reported E.P.S. of $-0.09 for its first fiscal quarter (ending March 31) versus $-0.14 for the same period a year ago. This performance was $-0.29 short of the consensus estimate […]
Agios Pharmaceuticals Inc (NASDAQ: AGIO) has reported a loss for its first fiscal quarter (ending March 31) of $-1.45 versus a loss $-1.47 for the same period a year ago. For the latest four quarters […]
On 5/2/24, Actinium Pharmaceuticals Inc (NYSEAMERICAN: ATNM) stock enjoyed a major increase of 12.5%, closing at $8.75. Moreover, unusually high trading volume at 158% of normal accompanied the advance. The stock has risen 23.9% during […]
Wave Life Sciences Ltd (NASDAQ: WVE) stock enjoyed a major increase of 15.0% on 5/1/24. The shares closed at $5.67. NORMAL trading volume accompanied the advance. The stock has performed in line with the market […]
Recent extremely meaningful negative changes in investment behavior have impacted The Clorox Co (NYSE: CLX): the stock’s recent price decline challenged its longer term uptrend, the stock fell on very heavy volume, and negative upside/downside […]
SunCoke Energy Inc (NYSE: SXC) has reported E.P.S. of $0.24 for its first fiscal quarter (ending March 31) versus $0.19 for the same period a year ago — an increase of 26%. For the latest […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research